Matthew Murphy | executive |
Christopher Posner | executive |
Ryan Maynard | executive |
Annabel Samimy | analyst |
Joana Goncalves | executive |
Joseph Stringer | analyst |
David Amsellem | analyst |
Thank you for standing by, and welcome to Cara Therapeutics Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions]
I would now like to hand the call over to Matt Murphy, Manager of Investor Relations. Please go ahead.
Thank you, operator, and good afternoon.